Jonathan Ayers

As Chairman and CEO of IDEXX Laboratories (NASDAQ: IDXX) from 2002 through 2019, Jon led a global team of over 8,000 employees dedicated to enhancing the health and well-being of pets. As a leading animal health company, IDEXX has invested more than 80% of the industry’s R&D in diagnostic and information technology, bringing novel offerings that significantly advanced the standard of care for veterinary medicine. During Jon’s tenure, the company grew annual revenues from $380 million to $2.4 billion, while the company’s share price enjoyed a more than 40-fold increase.

Jon has a degree from Yale in Molecular Biophysics and Biochemistry and an MBA from Harvard Business School where he graduated with high distinction (top 5%).